News

EIC Accelerator: 71 companies selected in october 2024 cut-off

Published on | 7 months ago

Programmes EIC

The European Innovation Council (EIC) selected 71 cutting edge companies for funding, combining grants and equity, following the last 2024 EIC Accelerator cut-off in October. They have been selected among 1211 submitted proposals, out of which 431 have been invited to the jury interviews.

21% of the selected companies are led by women (as CEO, CSO or CTO), while there is a geographical spread spanning 16 countries. 

Four of the selected companies have benefitted from the ‘Plug In’ scheme. The scheme allows funding bodies managing certified national/regional programmes to submit projects from their portfolio directly to the full application stage of the EIC Accelerator. 

A further 330 applications that were assessed positively by the EIC jury, but for which there was insufficient funding available, will be awarded a Seal of Excellence. This recognition helps these companies to find alternative funding sources, including from the Recovery and Resilience Funds and European Regional Development Funds.

3 Belgian organisations will receive blended financing.

More details available here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1706 articles available search in articles 

Testimonial

image of SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

SAPHIRe - Securing the Adoption of Personalised Medicin in Regions

The Department of Economy, Science and Innovation of the Flemish government coordinates the Horizon 2020 Coordination and Support Action SAPHIRe, which started on 1 December 2018. The aim of the project is to secure the adoption of personalised medicine in all European regions, including sparsely populated and remote regions and regions with different innovation capacities. 

The activities of SAPHIRe are complementary to the smart specialisation partnership on personalised medicine – S3P4PM, which is also coordinated by the Department of Economy, Science and Innovation.